Metabolic selection via asparagine biosynthesis pathway
AssigneeSigma-Aldrich Co.
InventorsJames Ravellette, Mary Otto, David Razafsky, Jason A. Gustin, Trissa Borgschulte
Life of this patent
Estimating the term…
Abstract
The present disclosure provides an isolated mammalian cell comprising a reduced or eliminated expression of Asparagine Synthetase (ASNS). Further provided are methods for preparing such cells and methods for using such cells for the production of recombinant proteins.
Claims25
A method for producing a recombinant protein product, the process comprising
- (a) providing a mammalian cell line engineered to have reduced or eliminated expression of endogenous asparagine synthetase (ASNS);
- (b) introducing into the mammalian cell line a polynucleotide, wherein the polynucleotide encodes a functional ASNS gene and the recombinant protein;
- (c) culturing the cell line;
- and
- (d) purifying the recombinant protein to form the recombinant protein product.
A genetically engineered mammalian cell line for use in a biologic production system, wherein the mammalian cell line is engineered to have reduced or eliminated expression of endogenous ASNS.
(canceled)
(canceled)
(canceled)
(canceled)
A polynucleotide comprising a nucleic acid sequence encoding a functional ASNS and at least one recombinant protein of interest.
(canceled)
Dependencies are inferred from the claim text.